{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:50:28Z","timestamp":1787532628430,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jtcvs.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T21:35:08Z","timestamp":1678743308000},"page":"523-532.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Direct oral anticoagulants for atrial fibrillation in early postoperative valve repair or bioprosthetic replacement"],"prefix":"10.1016","volume":"168","author":[{"given":"Nils","family":"Moser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri L.","family":"Koshman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Youngson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Harten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2023.03.004_bib1","first-page":"72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/europace\/eun273","article-title":"The significance of preoperative atrial fibrillation in patients undergoing cardiac surgery: preoperative atrial fibrillation\u2014still underestimated opponent","volume":"10","author":"Banach","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib3","first-page":"1847","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib4","first-page":"72","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"3","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib8","first-page":"1114","article-title":"2014 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"30","author":"Verma","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.116.026714","article-title":"Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves","volume":"135","author":"Carnicelli","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.amjcard.2021.01.016","article-title":"Comparison of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and bioprosthetic heart valves","volume":"146","author":"Duan","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/clc.23178","article-title":"Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trial","volume":"42","author":"Guimar\u00e3es","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s40261-020-00939-x","article-title":"Comparison of the efficacy and safety of direct oral anticoagulants and warfarin after bioprosthetic valve replacements","volume":"40","author":"Pasciolla","year":"2020","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib14","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jtcvs.2019.09.064","article-title":"Non-vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing","volume":"160","author":"Beller","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib15","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimar\u00e3es","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib16","article-title":"Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial","volume":"1-10","author":"Shim","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.athoracsur.2013.03.015","article-title":"Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery","volume":"96","author":"Ranucci","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib18","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000477164","article-title":"Perioperative strokes following surgical correction of mitral valves: a systematic review and meta-analysis","volume":"78","author":"Udesh","year":"2017","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib22","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.jacc.2017.09.1085","article-title":"2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology task force on expert consensus decision pathways","volume":"70","author":"Tomaselli","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.h246","article-title":"The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study","volume":"350","author":"Jun","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamainternmed.2019.6447","article-title":"Association of ticagrelor versus clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"180","author":"Turgeon","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/europace\/euz302","article-title":"Impact of cardiology follow-up care on treatment and outcomes of patients with new atrial fibrillation discharged from the emergency department","volume":"22","author":"Hawkins","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib26","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000174293.17959.a1","article-title":"Coding of stroke and stroke risk factors using International Classification of Diseases, Revisions 9 and 10","volume":"36","author":"Kokotailo","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib27","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.19102\/icrm.2017.080302","article-title":"Time in the therapeutic range (TTR): an overly simplified conundrum","volume":"8","author":"Reiffel","year":"2017","journal-title":"J Innov Card Rhythm Manag"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/MJT.0000000000001413","article-title":"Risk of stroke after transcatheter aortic valve implantation: epidemiology, mechanism, and management","volume":"28","author":"Ciobanu","year":"2021","journal-title":"Am J Ther"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib29","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/dj4010005","article-title":"New direct oral anticoagulants (DOAC) and their use today","volume":"4","author":"Schwarb","year":"2016","journal-title":"Dent J"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib31","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib32","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.athoracsur.2019.07.033","article-title":"Causes, risk factors, and costs of 30-day readmissions after mitral valve repair and replacement","volume":"108","author":"Goel","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib33","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0735-1097(00)01202-X","article-title":"Prediction of operative mortality after valve replacement surgery","volume":"37","author":"Edwards","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib34","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/CIRCULATIONAHA.113.002200","article-title":"Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries","volume":"127","author":"Vassileva","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib35","author":"Belley-Cote"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.amjcard.2021.01.016","article-title":"Comparison of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and bioprosthetic heart valves","volume":"146","author":"Duan","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.h246","article-title":"The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study","volume":"350","author":"Jun","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamainternmed.2019.6447","article-title":"Association of ticagrelor versus clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"180","author":"Turgeon","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/europace\/euz302","article-title":"Impact of cardiology follow-up care on treatment and outcomes of patients with new atrial fibrillation discharged from the emergency department","volume":"22","author":"Hawkins","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jtcvs.2023.03.004_bib40","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000174293.17959.a1","article-title":"Coding of stroke and stroke risk factors using International Classification of Diseases, Revisions 9 and 10","volume":"36","author":"Kokotailo","year":"2005","journal-title":"Stroke"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522323001988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522323001988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:15:37Z","timestamp":1785550537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522323001988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0022522323001988"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2023.03.004","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulants for atrial fibrillation in early postoperative valve repair or bioprosthetic replacement","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}